erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

Amplification and overexpression of the erbB-2 oncogene is an unfavourable prognostic marker in human breast cancer and occurs in approximately 25% of breast carcinomas. We used erbB-2 antisense oligonucleotides to inhibit the proliferation of human breast cancer cell lines. erbB-2 antisense oligonu...

Descripción completa

Detalles Bibliográficos
Autores principales: Colomer, R., Lupu, R., Bacus, S. S., Gelmann, E. P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033560/
https://www.ncbi.nlm.nih.gov/pubmed/7947086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033560/
https://www.ncbi.nlm.nih.gov/pubmed/7947086

Ejemplares similares